Ventria’s BioShare Program
Ventria’s BioShare Program provides an opportunity for academic and government researchers to gain access to recombinant proteins and peptides for their research. Researchers interested in this program should send an email to Info@Ventria.com and describe their research, the potential outcomes, potential commercial applications resulting from the research and the amount of recombinant protein required. Currently, Ventria offers qualified researchers access to the following proteins:
- Recombinant albumin
- Recombinant lactoferrin
- Recombinant lysozyme
- Recombinant transferrin
Benefits for Researchers
In the past, it has been difficult for researchers to conduct extensive studies on recombinant proteins or peptides because these materials were cost prohibitive and sufficient quantities were not readily available. Ventria’s BioShare program allows researchers to enhance and extend their research leading to additional scientific publications and improves the speed that new discoveries emerge from their research.
Benefits for Ventria
Ventria’s mission is to develop breakthrough products that enhance and save lives. Ventria believes its recombinant proteins hold tremendous promise as treatments for numerous health problems. Ventria has developed the BioShare Program to generate additional data on the activity of these proteins and initiate additional commercial development with these proteins.
If you are interested in talking to Ventria about qualifying to become a BioShare researcher or would like more information, please send an email to Info@Ventria.com or contact us at 1-800-916-8311.